Loading clinical trials...
Loading clinical trials...
Type of Study: Randomized Controlled Trial Aim: To compare the effectiveness of two doses of sucrose solution for pain relief in neonates after minor procedures. Participants' Tasks: Receive either 0.2 ml or 0.5 ml of sucrose solution. Undergo minor procedures. Pain intensity assessment using the Premature Infant Pain Profile (PIPP). Comparison Groups: Researchers compared the effects of administering 0.2 ml and 0.5 ml doses of sucrose solution on post-procedural pain in neonates.
This study is a randomized controlled trial conducted at the Department of Pediatric Surgery, Holy Family Hospital, Rawalpindi, from March 2023 to February 2024. It aims to compare the effectiveness of two different doses of sucrose solution (0.2 ml versus 0.5 ml) for pain relief in neonates after minor procedures. Objective: To compare the outcome of 0.2 ml versus 0.5 ml sucrose solution for pain relief in neonates after minor procedures. Study Design: Randomized Controlled Trial Study Place and Duration: Department of Pediatric Surgery, Holy Family Hospital, Rawalpindi, March 2023 to February 2024. Participants and Methods: Total of 148 neonates enrolled who underwent minor procedures and were admitted to the neonatal intensive care unit. Randomly divided into two groups: Group I: Administered 0.2 ml of sucrose solution Group II: Administered 0.5 ml of sucrose solution Pain intensity measured using the Premature Infant Pain Profile (PIPP). Data analyzed using SPSS version 25.0.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
Yes
Mehak Fatima
Rawalpindi, Punjab Province, Pakistan
Start Date
March 1, 2023
Primary Completion Date
February 29, 2024
Completion Date
February 29, 2024
Last Updated
June 6, 2024
148
ACTUAL participants
0.2 ml dose of sucrose
DRUG
Lead Sponsor
Rawalpindi Medical College
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions